Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation ...
Matthews International Balances Strategic Reset With Operational Growing Pains The tone of Matthews International’s latest earnings call mixed confidence in a transformed balance sheet with caution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results